Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Hepatitis C

Free Subscription Articles published in J Gastroenterol Retrieve available abstracts of 39 articles: HTML format Text format

Single Articles

March 2012
1. KOBAYASHI T , Hige S, Terashita K, Nakai M, et al
   Anemia and thrombocytosis induced by ribavirin monotherapy in patients with chronic hepatitis C.
   J Gastroenterol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. KIM SR , El-Shamy A, Imoto S, Kim KI, et al
   Prediction of response to pegylated interferon/ribavirin combination therapy for chronic hepatitis C genotype 1b and high viral load.
   J Gastroenterol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. KOBAYASHI M , Suzuki F, Akuta N, Sezaki H, et al
   Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus.
   J Gastroenterol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. FENG J , Hu X, Guo H, Sun X, et al
   Patients with chronic hepatitis C express a high percentage of CD4(+)CXCR5 (+) T follicular helper cells.
   J Gastroenterol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. IKEDA H , Tejima K, Masuzaki R, Yatomi Y, et al
   Reply to the letter by H. Mawatari et al. regarding "Thrombocytopenia is more severe in patients with advanced chronic hepatitis C than B with the same grade of liver stiffness and splenomegaly"
   J Gastroenterol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
6. MAWATARI H , Yoneda M, Kirikoshi H, Maeda S, et al
   Thrombocytopenia is more severe in patients with chronic hepatitis C than in patients with nonalcoholic fatty liver disease.
   J Gastroenterol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
7. MIYASE S , Haraoka K, Ouchida Y, Morishita Y, et al
   Randomized trial of peginterferon alpha-2a plus ribavirin versus peginterferon alpha-2b plus ribavirin for chronic hepatitis C in Japanese patients.
   J Gastroenterol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2012
8. TSENG KC , Ho YC, Hsieh YH, Lai NS, et al
   Elevated frequency and function of regulatory T cells in patients with active chronic hepatitis C.
   J Gastroenterol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. OHNISHI M , Tsuge M, Kohno T, Zhang Y, et al
   IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients.
   J Gastroenterol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
10. OZE T , Hiramatsu N, Song C, Yakushijin T, et al
    Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. OSAKI Y , Ueda Y, Marusawa H, Nakajima J, et al
    Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. MINISINI R , Giarda P, Grossi G, Bitetto D, et al
    Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome.
    J Gastroenterol. 2011;46:1307-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
13. TAKESHITA S , Ichikawa T, Taura N, Miyaaki H, et al
    Geranylgeranylacetone has anti-hepatitis C virus activity via activation of mTOR in human hepatoma cells.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
14. KANTO T , Inoue M, Oze T, Miyazaki M, et al
    Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C patients.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. WEICH V , Herrmann E, Chung TL, Sarrazin C, et al
    The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infection.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
16. HIRAMATSU N , Inoue Y, Oze T, Kurashige N, et al
    Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case-control study.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
17. HIRAMATSU N , Kurosaki M, Sakamoto N, Iwasaki M, et al
    Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. MURAKAMI K , Takahashi R, Ono M, Watanabe K, et al
    Serodiagnosis of Helicobacter hepaticus infection in patients with liver and gastrointestinal diseases: western blot analysis and ELISA using a highly specific monoclonal antibody for H. hepaticus antigen.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
19. TAHARA H , Takagi H, Sato K, Shimada Y, et al
    A retrospective cohort study of partial splenic embolization for antiviral therapy in chronic hepatitis C with thrombocytopenia.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. MIYAGI T , Shimizu S, Tatsumi T, Nishio K, et al
    Differential alteration of CD56(bright) and CD56 (dim) natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. OZEKI I , Akaike J, Karino Y, Arakawa T, et al
    Antiviral effects of peginterferon alpha-2b and ribavirin following 24-week monotherapy of telaprevir in Japanese hepatitis C patients.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. OZE T , Hiramatsu N, Yakushijin T, Mochizuki K, et al
    The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. OZE T , Hiramatsu N, Yakushijin T, Mochizuki K, et al
    Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
24. SCHWARZ P , Strnad P, von Figura G, Janetzko A, et al
    A novel monoclonal antibody immunoassay for the detection of human serum hepcidin.
    J Gastroenterol. 2011;46:648-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
25. NAGAOKI Y , Aikata H, Miyaki D, Murakami E, et al
    Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
26. TAKAHASHI H , Mizuta T, Eguchi Y, Kawaguchi Y, et al
    Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. DOLGANIUC A , Szabo G
    Dendritic cells in hepatitis C infection: can they (help) win the battle?
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
28. CHAYAMA K , Hayes CN, Yoshioka K, Moriwaki H, et al
    Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
29. KUMADA T , Toyoda H, Kiriyama S, Tanikawa M, et al
    Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
30. KOBAYASHI Y , Kawaguchi Y, Mizuta T, Kuwashiro T, et al
    Metabolic factors are associated with serum alanine aminotransferase levels in patients with chronic hepatitis C.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
31. TOYODA H , Kumada T, Kiriyama S, Tanikawa M, et al
    High ability to predict the treatment outcome of peginterferon and ribavirin combination therapy based on the reduction in HCV RNA levels at 4 weeks after starting therapy and amino acid substitutions in the hepatitis C virus in patients infected with
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
32. KUROSAKI M , Sakamoto N, Iwasaki M, Sakamoto M, et al
    Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
33. KONDO Y , Ueno Y, Kakazu E, Kobayashi K, et al
    Lymphotropic HCV strain can infect human primary naive CD4(+) cells and affect their proliferation and IFN-gamma secretion activity.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. TATEYAMA M , Yatsuhashi H, Taura N, Motoyoshi Y, et al
    Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. MORIKAWA H , Fukuda K, Kobayashi S, Fujii H, et al
    Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
36. AHLENSTIEL G , Booth DR, George J
    IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
37. TOKUSHIGE K , Hashimoto E, Yatsuji S, Tobari M, et al
    Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
38. TEJIMA K , Masuzaki R, Ikeda H, Yoshida H, et al
    Thrombocytopenia is more severe in patients with advanced chronic hepatitis C than B with the same grade of liver stiffness and splenomegaly.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2009
39. MICHITAKA K , Nishiguchi S, Aoyagi Y, Hiasa Y, et al
    Etiology of liver cirrhosis in Japan: a nationwide survey.
    J Gastroenterol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from F. Hoffmann-La Roche.

Amedeo is a Flying Publisher website.    Design: